Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1238

1.

Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis.

Vuorio T, Nurmi H, Moulton K, Kurkipuro J, Robciuc MR, Ohman M, Heinonen SE, Samaranayake H, Heikura T, Alitalo K, Ylä-Herttuala S.

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1162-70. doi: 10.1161/ATVBAHA.114.302528. Epub 2014 Apr 10.

PMID:
24723556
[PubMed - indexed for MEDLINE]
2.

Is the superiority of apoB over non-HDL-C as a marker of cardiovascular risk in the INTERHEART study due to confounding by related variables?

Sniderman AD, Islam S, Yusuf S, McQueen MJ.

J Clin Lipidol. 2013 Nov-Dec;7(6):626-31. doi: 10.1016/j.jacl.2013.08.004. Epub 2013 Aug 31.

PMID:
24314360
[PubMed - indexed for MEDLINE]
3.

ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.

de Nijs T, Sniderman A, de Graaf J.

Crit Rev Clin Lab Sci. 2013 Nov;50(6):163-71. doi: 10.3109/10408363.2013.847897. Review.

PMID:
24295059
[PubMed - indexed for MEDLINE]
4.

APOE p.Leu167del mutation in familial hypercholesterolemia.

Awan Z, Choi HY, Stitziel N, Ruel I, Bamimore MA, Husa R, Gagnon MH, Wang RH, Peloso GM, Hegele RA, Seidah NG, Kathiresan S, Genest J.

Atherosclerosis. 2013 Dec;231(2):218-22. doi: 10.1016/j.atherosclerosis.2013.09.007. Epub 2013 Sep 19.

PMID:
24267230
[PubMed - indexed for MEDLINE]
5.

Apoprotein B, small-dense LDL and impaired HDL remodeling is associated with larger plaque burden and more noncalcified plaque as assessed by coronary CT angiography and intravascular ultrasound with radiofrequency backscatter: results from the ATLANTA I study.

Voros S, Joshi P, Qian Z, Rinehart S, Vazquez-Figueroa JG, Anderson H, Elashoff M, Murrieta L, Karmpaliotis D, Kalynych A, Brown C 3rd, Schaefer E, Asztalos B.

J Am Heart Assoc. 2013 Nov 19;2(6):e000344. doi: 10.1161/JAHA.113.000344.

PMID:
24252842
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Importance of evaluating cell cholesterol influx with efflux in determining the impact of human serum on cholesterol metabolism and atherosclerosis.

Weibel GL, Drazul-Schrader D, Shivers DK, Wade AN, Rothblat GH, Reilly MP, de la Llera-Moya M.

Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):17-25. doi: 10.1161/ATVBAHA.113.302437. Epub 2013 Nov 7.

PMID:
24202308
[PubMed - indexed for MEDLINE]
7.

Association of the MLXIPL/TBL2 rs17145738 SNP and serum lipid levels in the Guangxi Mulao and Han populations.

Zeng XN, Yin RX, Huang P, Huang KK, Wu J, Guo T, Lin QZ, Aung LH, Wu JZ, Wang YM.

Lipids Health Dis. 2013 Oct 25;12:156. doi: 10.1186/1476-511X-12-156.

PMID:
24160749
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

[Clinical significance of non-high-density lipoprotein cholesterol and its application in pediatrics].

Chen LH, Shi XF, Liang L.

Zhonghua Er Ke Za Zhi. 2013 Jun;51(6):436-8. Review. Chinese. No abstract available.

PMID:
24120061
[PubMed - indexed for MEDLINE]
9.

Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.

Hurt-Camejo E, Gautier T, Rosengren B, Dikkers A, Behrendt M, Grass DS, Rader DJ, Tietge UJ.

Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2707-14. doi: 10.1161/ATVBAHA.113.301410. Epub 2013 Oct 10.

PMID:
24115030
[PubMed - indexed for MEDLINE]
10.

Background diet and fat type alters plasma lipoprotein response but not aortic cholesterol accumulation in F1B Golden Syrian hamsters.

Dillard A, Matthan NR, Spartano NL, Butkowski AE, Lichtenstein AH.

Lipids. 2013 Dec;48(12):1177-84. doi: 10.1007/s11745-013-3840-0. Epub 2013 Oct 6.

PMID:
24096944
[PubMed - indexed for MEDLINE]
11.

Serum creatinine is associated with coronary disease risk even in the absence of metabolic disorders.

Onat A, Yüksel H, Can G, Köroğlu B, Kaya A, Altay S.

Scand J Clin Lab Invest. 2013 Oct;73(7):569-75. doi: 10.3109/00365513.2013.821712.

PMID:
24094290
[PubMed - indexed for MEDLINE]
12.

Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: a randomised cross-over intervention in mature women.

Tovar J, Nilsson A, Johansson M, Björck I.

Br J Nutr. 2014 Feb;111(4):706-14. doi: 10.1017/S000711451300305X. Epub 2013 Sep 24.

PMID:
24063257
[PubMed - indexed for MEDLINE]
13.

Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges.

Rosenson RS, Brewer HB Jr, Ansell B, Barter P, Chapman MJ, Heinecke JW, Kontush A, Tall AR, Webb NR.

Circulation. 2013 Sep 10;128(11):1256-67. doi: 10.1161/CIRCULATIONAHA.113.000962. Review. No abstract available.

PMID:
24019446
[PubMed - indexed for MEDLINE]
14.

Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.

Thomas GS, Cromwell WC, Ali S, Chin W, Flaim JD, Davidson M.

J Am Coll Cardiol. 2013 Dec 10;62(23):2178-84. doi: 10.1016/j.jacc.2013.07.081. Epub 2013 Sep 4.

PMID:
24013058
[PubMed - indexed for MEDLINE]
15.

Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.

Kim DW, Lee SY, Shon YM, Kim JH.

Epilepsia. 2013 Oct;54(10):e146-9. doi: 10.1111/epi.12338. Epub 2013 Aug 23.

PMID:
23980720
[PubMed - indexed for MEDLINE]
16.

Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).

Albers JJ, Slee A, O'Brien KD, Robinson JG, Kashyap ML, Kwiterovich PO Jr, Xu P, Marcovina SM.

J Am Coll Cardiol. 2013 Oct 22;62(17):1575-9. doi: 10.1016/j.jacc.2013.06.051. Epub 2013 Aug 21.

PMID:
23973688
[PubMed - indexed for MEDLINE]
17.

Stabilization of atherosclerotic plaques: an update.

Ylä-Herttuala S, Bentzon JF, Daemen M, Falk E, Garcia-Garcia HM, Herrmann J, Hoefer I, Jauhiainen S, Jukema JW, Krams R, Kwak BR, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys PW, Waltenberger J, Weber C, Tokgözoglu L; ESC Working Group of Atherosclerosis and Vascular Biology.

Eur Heart J. 2013 Nov;34(42):3251-8. doi: 10.1093/eurheartj/eht301. Epub 2013 Aug 21. No abstract available.

PMID:
23966311
[PubMed - indexed for MEDLINE]
18.

New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.

Sahebkar A, Watts GF.

Clin Ther. 2013 Aug;35(8):1082-98. doi: 10.1016/j.clinthera.2013.06.019. Epub 2013 Aug 8. Review.

PMID:
23932550
[PubMed - indexed for MEDLINE]
Free Article
19.

Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study.

Sondermeijer BM, Rana JS, Arsenault BJ, Shah PK, Kastelein JJ, Wareham NJ, Boekholdt SM, Khaw KT.

Eur J Clin Invest. 2013 Oct;43(10):1009-15. doi: 10.1111/eci.12129. Epub 2013 Jul 17.

PMID:
23859101
[PubMed - indexed for MEDLINE]
20.

Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.

Bi X, Zhu X, Duong M, Boudyguina EY, Wilson MD, Gebre AK, Parks JS.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2288-96. doi: 10.1161/ATVBAHA.112.301110. Epub 2013 Jun 27.

PMID:
23814116
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk